Entero Healthcare Solutions Limited (NSE:ENTERO)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Pharmaceutical and Surgical Products	38.88B	Log In	Log In	Log In
Pharmaceutical and Surgical Products Growth	18.07%	Log In	Log In	Log In
Other	341.47M	Log In	Log In	Log In
Other Growth	383.39%	Log In	Log In	Log In

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
India	39.22B	Log In	Log In	Log In
India Growth	18.85%	Log In	Log In	Log In